Impacts of Completion Lymph Node Dissection and Adjuvant Therapies in Japanese Stage III Melanoma Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Impact of the changes in the completion lymph node dissection criteria and approval of adjuvant therapies on the real-world outcomes of Japanese stage III melanoma patients
Int. J. Clin. Oncol. 2021 Dec 01;26(12)2338-2346, D Ogata, K Tanese, Y Nakamura, M Otsuka, K Namikawa, T Funakoshi, S Yoshikawa, K Tsutsui, K Nakama, S Jinnai, Y Kiyohara, A Takahashi, N YamazakiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.